(Q40845651)

24 September 2017

title

Oncolytic potential of E1B 55 kDa-deleted YKL-1 recombinant adenovirus: correlation with p53 functional status (English)

1 reference

24 September 2017

1 reference

1 reference

8

1 reference

24 September 2017

H Lee

1

1 reference

24 September 2017

J Kim

2

1 reference

24 September 2017

B Lee

3

1 reference

24 September 2017

J W Chang

4

1 reference

24 September 2017

J Ahn

5

1 reference

24 September 2017

J O Park

6

1 reference

24 September 2017

J Choi

7

1 reference

24 September 2017

B S Kim

9

1 reference

24 September 2017

J H Kim

10

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

International Journal of Cancer

24 September 2017

published in

1 reference

24 September 2017

volume

88

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

454-463

1 reference

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

Abnormal structure and expression of p53 gene in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

Implications of the p53 tumor-suppressor gene in clinical oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

E1A oncogene-induced cellular sensitization to immune-mediated apoptosis is independent of p53 and resistant to blockade by E1B 19 kDa protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

trans E1 component requirements for maximal replication of E1-defective recombinant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

p53-dependent cell death/apoptosis is required for a productive adenovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

Clinical implications of the p53 tumor-suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

Targeting the replication of adenoviral gene therapy vectors to lung cancer cells: the importance of the adenoviral E1b-55kD gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

Stabilization of p53 by adenovirus E1A occurs through its amino-terminal region by modification of the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

Cancer gene therapy annual conference 1997: trends and news

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

Gene therapy for cancer: what have we done and where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

Gene therapy -- promises, problems and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

p53 function and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

ONYX-015: clinical data are encouraging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

Tumor-suppressor p53: implications for tumor development and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001101%2988%3A3%3C454%3A%3AAID-IJC19%3E3.0.CO%3B2-T

10.1002/1097-0215(20001101)88:3<454::AID-IJC19>3.0.CO;2-T

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference